ALLOZYNE INC — Form D
ALLOZYNE INC of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2013-04-05. The offering totals $1.8M, of which $900K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-04-05
- Form: D
- Accession: 0001345630-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.8M
- Amount sold: $900K
- Remaining: $900K
- Investors: 10
- Date of first sale: 2013-03-22
- Revenue range: Decline to Disclose
- SEC file number: 021-194545
Issuer
- Name: ALLOZYNE INC
- CIK: 0001345630
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1600 FAIRVIEW AVE EAST, SEATTLE, WA, 98102
- Phone: 206-957-7300
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Steven Gillis | Director | South San Francisco, CA |
| John Bencich | Executive Officer | Vancouver, A1 |
| Carl Weissman | Director | San Diego, CA |
| Michael Steinmetz | Director | Ann Arbor, MI |
| MEENU CHHABRA | Director | CAMBRIDGE, MA |
| MEENU CHHABRA | Executive Officer | CAMBRIDGE, MA |
| David Tirrell | Director | Seattle, WA |
| Kenneth Grabstein | Executive Officer | Seattle, WA |
Other filings by this issuer (4)
More